News News Select Year All Years 2026 (16) 2025 (34) 2024 (29) 2023 (30) 2022 (33) 2021 (27) 2020 (34) 2019 (32) 2018 (42) 2017 (35) 2016 (43) 2015 (53) 2014 (26) 2013 (21) 2012 (16) 2011 (6) 2010 (4) 2009 (5) 2007 (1) 2006 (1) Search News Found 488 Results Page 45 of 49« First«...102030...4344454647...»Last » October 18, 2013 Stallergenes and DBV Technologies Announce Respiratory Allergy Research and Development Collaboration for Birch Pollen October 15, 2013 DBV Announces Topline Financial Results for First Nine Months 2013 and Provides Safety Update on Viaskin® Peanut September 4, 2013 DBV Technologies initiates a long-term follow-up study of Viaskin Peanut July 8, 2013 DBV Technologies completes enrollment of Phase IIb VIPES study, the first-ever global trial in desensitization to peanut allergy June 28, 2013 DBV Technologies announces breakthrough Data Presentations at EAACI-WAO Congress June 20, 2013 Viaskin Peanut demonstrates strong efficacy trend in severely peanut-allergic children in 18-month results of ARACHILD pilot study June 4, 2013 DBV Technologies’ June 4th, 2013 Combined Shareholders’s Meeting May 16, 2013 Stallergenes and DBV Technologies enter into partnership for the development of innovative treatment of respiratory allergies May 7, 2013 DBV Technologies and Mount Sinai Hospital enter into a Research Collaboration Agreement April 25, 2013 DBV Technologies publishes its 2012 Registration Document and its 2012 Annual Financial Report Page 45 of 49« First«...102030...4344454647...»Last »
